These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20890443)

  • 21. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
    Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
    Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
    Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
    J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.
    Bae BI; Xu H; Igarashi S; Fujimuro M; Agrawal N; Taya Y; Hayward SD; Moran TH; Montell C; Ross CA; Snyder SH; Sawa A
    Neuron; 2005 Jul; 47(1):29-41. PubMed ID: 15996546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomic Nuclear Magnetic Resonance Studies at Presymptomatic and Symptomatic Stages of Huntington's Disease on a
    Bertrand M; Decoville M; Meudal H; Birman S; Landon C
    J Proteome Res; 2020 Oct; 19(10):4034-4045. PubMed ID: 32880177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington's disease patients.
    Pierzynowska K; Gaffke L; Cyske Z; Węgrzyn G
    Metab Brain Dis; 2019 Jun; 34(3):715-720. PubMed ID: 30850940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using Drosophila models of Huntington's disease as a translatable tool.
    Lewis EA; Smith GA
    J Neurosci Methods; 2016 May; 265():89-98. PubMed ID: 26241927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A small-molecule therapeutic lead for Huntington's disease: preclinical pharmacology and efficacy of C2-8 in the R6/2 transgenic mouse.
    Chopra V; Fox JH; Lieberman G; Dorsey K; Matson W; Waldmeier P; Housman DE; Kazantsev A; Young AB; Hersch S
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16685-9. PubMed ID: 17925440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
    Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
    J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington's disease.
    Kuljis D; Schroeder AM; Kudo T; Loh DH; Willison DL; Colwell CS
    Minerva Pneumol; 2012 Sep; 51(3):93-106. PubMed ID: 23687390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep Physiology Alterations Precede Plethoric Phenotypic Changes in R6/1 Huntington's Disease Mice.
    Lebreton F; Cayzac S; Pietropaolo S; Jeantet Y; Cho YH
    PLoS One; 2015; 10(5):e0126972. PubMed ID: 25966356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
    Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
    Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective role of Engrailed in a Drosophila model of Huntington's disease.
    Mugat B; Parmentier ML; Bonneaud N; Chan HY; Maschat F
    Hum Mol Genet; 2008 Nov; 17(22):3601-16. PubMed ID: 18718937
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Arabit JGJ; Elhaj R; Schriner SE; Sevrioukov EA; Jafari M
    Biomed Res Int; 2018; 2018():6726874. PubMed ID: 29984244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.
    Kacher R; Lamazière A; Heck N; Kappes V; Mounier C; Despres G; Dembitskaya Y; Perrin E; Christaller W; Sasidharan Nair S; Messent V; Cartier N; Vanhoutte P; Venance L; Saudou F; Néri C; Caboche J; Betuing S
    Brain; 2019 Aug; 142(8):2432-2450. PubMed ID: 31286142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.
    Kolli N; Lu M; Maiti P; Rossignol J; Dunbar GL
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic-endocrine aspects in Huntington's disease.
    Petersén A; Björkqvist M
    Eur J Neurosci; 2006 Aug; 24(4):961-7. PubMed ID: 16925587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonmammalian Models of Huntington's Disease.
    Chongtham A; Barbaro B; Filip T; Syed A; Huang W; Smith MR; Marsh JL
    Methods Mol Biol; 2018; 1780():75-96. PubMed ID: 29856015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serine residues 13 and 16 are key modulators of mutant huntingtin induced toxicity in Drosophila.
    Chatterjee M; Steffan JS; Lukacsovich T; Marsh JL; Agrawal N
    Exp Neurol; 2021 Apr; 338():113463. PubMed ID: 32941796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease.
    Naphade S; Embusch A; Madushani KL; Ring KL; Ellerby LM
    Front Neurosci; 2017; 11():736. PubMed ID: 29459817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.